Vadim Kolesnikov, MD
Diagnostic Radiology · Brooklyn, NYNPI 1871652974
Payments from drug & device makers
Across 46 payments — averaging $281.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$11K
- Abbott$674
- Curonix LLC$305
- Penumbra, Inc.$160
- AbbVie$125
- Organogenesis Inc.$79
- plus $216 from 6 others
What the payments were for
- Travel & lodging$2892%
- Food & beverage$1,31110%
- Education$11,33388%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 4 | $11,375 |
| Abbott | 25 | $674 |
| Curonix LLC | 3 | $305 |
| Penumbra, Inc. | 1 | $160 |
| AbbVie | 1 | $125 |
| Organogenesis Inc. | 1 | $79 |
| E.r. Squibb & Sons, L.L.C. | 4 | $64 |
| Boston Scientific | 2 | $53 |
| Biocompatibles, Inc. | 2 | $38 |
| Melinta Therapeutics, LLC | 1 | $24 |
| Terumo Medical Corporation | 1 | $22 |
| Advanced Oxygen Therapy Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,934 in reported general payments places this provider in the 90th percentile of 2,530 diagnostic radiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $49,597 |
| XareltoRivaroxaban | 74 | $45,753 |
| Diclofenac Sodium | 51 | $37,199 |
| Cefpodoxime Proxetil | 38 | $1,187 |
| ClopidogrelClopidogrel Bisulfate | 227 | $650 |
| Etodolac ErEtodolac | 24 | $621 |
| Cilostazol | 12 | $98 |
| Cephalexin | 35 | $84 |
| Ciprofloxacin Hcl | 11 | $75 |
| Ibuprofen | 30 | $59 |
| Naproxen | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other diagnostic radiology in Brooklyn
- Ilan Rzadkowolsky-RaoliBrooklyn$326K
- Derace SchafferRochester$8.5M
- Constantinos SofocleousNew York$5.6M
- Lawrence SchwartzNew York$5.3M
- Thomas SosNew York$3.5M
- Hollis PotterNew York$3.1M
- Bachir TaouliNew York$1.7M
- Kevin BakerStony Brook$1.6M
- Lawrence TanenbaumNew York$1.5M
- Pina SanelliNew York$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.